Novel device for obstructive sleep apnea in Down Syndrome

Year 2020
Project team Ellen Roche, Ravi Rasalingam & Tarsha Ward with David Vaknin, Daniel Gottlieb, and Fernando Deleon
Sleep apnea can have long-term effects in patients
Disruptive treatments lead many to avoid them
Discreet device aimed at providing effective, comfortable treatment

Custom-fit oral device

Obstructive sleep apnea (OSA) is marked by repetitive obstructions of the airway as muscle tone reduces during sleep. This team has created a custom-fit oral prosthesis with a pump that stabilizes the mouth muscles and prevents obstruction of the airway at night. The prosthesis could have a positive impact in particular on the Down Syndrome patient community, which has a high prevalence of OSA. Current treatments are cumbersome, uncomfortable, and disrupt the normal sleeping environment, leading to noncompliance among patients. Serious, long-term consequences associated with lack of treatment for OSA in Down Syndrome patients include impaired cognitive development, reduced independence, and cardiovascular disease. The team’s goal is to provide a therapy that is discreet, comfortable for regular use, and effective in reducing apnea episodes.

This project is funded by the Alana TTIA program at the Deshpande Center.

Ravi Rasalingam & Tarsha Ward present a Novel Discreet Treatment for Obstructive Sleep Apnea at Ideastream 2024